The trial missed its primary endpoint, Helsinn discontinued ipamorelin development, and no Phase 3 trial in any indication has ever been attempted by any sponsor
In a randomized controlled trial, Falutz et al., New England Journal of Medicine (2010) found that Tesamorelin significantly reduced VAT in HIV-infected patients with abdominal fat accumulation, leading to a healthier body composition and reduced cardiometabolic risk
Structural Modification The modification involves deletion of the first three N-terminal amino acids (glycine-proline-glutamate) from the 70-amino acid native IGF-1 sequence, creating a 67-amino acid variant with profound implications for receptor binding, bioavailability, and biological activity
Toxins from environmental pollutants, processed foods, alcohol consumption, and smoking can deplete glutathione stores in the body
Usage: This product is intended strictly as a research chemical and is limited to scientific research and education only